Atrix, Sanofi deal

ATRX received a $6 million payment from partner Sanofi, triggered by Sanofi's May launch in the U.S. of ATRX's Eligard 7.5 mg one-month leuprolide luteinizing hormone-releasing hormone agonist depot...